Switch to
View more

Krebs Biochemicals and Industries Ltd

KREBSBIO
Health CarePharmaceuticals
SmallcapWith a market cap of ₹238 cr, stock is ranked 1,641
High RiskStock is 3.69x as volatile as Nifty
109.301.35 (-1.22%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹238 cr, stock is ranked 1,641
High RiskStock is 3.69x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
-5.36
PB RatioPB Ratio
-18.74
Dividend YieldDiv. Yield
Sector PESector PE
38.37
Sector PBSector PB
4.84
Sector Div YldSctr Div Yld
0.91%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Krebs Biochemicals and Industries Limited is engaged in the business of manufacture of active pharmaceutical ingredients. The Company is producing a number of pain killers, anti-asthmatic and anti-human immunodeficiency virus (HIV) drugs.

Financial TrendFinancial statements 

201920202021202248.2033.7854.3260.86-20.01-28.87-28.35-44.53
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Newspaper Advertisements 
Announced OnAug 2, 2022

Krebs Biochemicals and Industries Limited has informed the Exchange about Newspaper Advertisements | Download

Krebs Biochemicals and Industries Limited has informed the Exchange about Newspaper Advertisements | Download

General updates 
Announced OnAug 1, 2022

Krebs Biochemicals and Industries Limited has informed the Exchange about intimation under regulation 30 of LODR regarding cessation of Ms.Taruni Banda as Company Secretary and Compliance officer w.e.f 6th August, 2022. | Download

Krebs Biochemicals and Industries Limited has informed the Exchange about intimation under regulation 30 of LODR regarding cessation of Ms.Taruni Banda as Company Secretary and Compliance officer w.e.f 6th August, 2022. | Download

Outcome of Board Meeting 
Announced OnAug 1, 2022

Krebs Biochemicals and Industries Limited has informed the Exchange about Board Meeting held on 01-Aug-2022 to consider financial statements for the period ended June 2022 and Other business matters | Download

Krebs Biochemicals and Industries Limited has informed the Exchange about Board Meeting held on 01-Aug-2022 to consider financial statements for the period ended June 2022 and Other business matters | Download

See all events